ArticleBlood advances2018
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.
Xiaoli Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papertrialcites it